| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/28/2004 | CN1515894A Checking zone colour-reaction judgement method of test piece |
| 07/28/2004 | CN1515893A Analyzed material detector with snake-shaped test paper channel |
| 07/28/2004 | CN1515891A Device for combining point light source with single lens |
| 07/28/2004 | CN1515785A Equipment and method for defining drilling mode and using optimized formation to make assess measurement |
| 07/28/2004 | CN1515681A Stability indicator |
| 07/28/2004 | CN1515680A Application of ion channel inhibitor for curing arhythmia |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515541A Method for detecting ligand pair combination by using non-fluorescent marker and its composite |
| 07/28/2004 | CN1515286A Chinese medicinal herb extractive |
| 07/28/2004 | CN1159585C Method for determining leptin |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159583C Detection of analtes by fluoresce lanthanide metal chelates |
| 07/28/2004 | CN1159582C Method for detecting total PSA value and total PSA gray zone value in whole blood or serum of human body |
| 07/28/2004 | CN1159581C Protein chip for immunological analysis |
| 07/28/2004 | CN1159580C Reagent for colloidal gold chromatographic analysis of SARS coronaviurs antigen |
| 07/28/2004 | CN1159579C Macromolecular weight protein reference material for active electrophoresis |
| 07/28/2004 | CN1159577C Method for determining magnesium content in molten aluminium alloy |
| 07/28/2004 | CN1159457C DNA Sequencing method |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159452C Method and compositions for detecting binding of ligand pair using non-fluorescent label |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/28/2004 | CN1159287C Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CA2456621A1 Determination of the age, identification and sealing of a product containing volatile components |
| 07/28/2004 | CA2456285A1 Fluorimetric determination of analytes by an intramolecular quencher-fluorophore conjugate |
| 07/27/2004 | US6768105 Methods and apparatus for downhole fluids analysis |
| 07/27/2004 | US6768062 Connection method and connection structure of pad electrodes, and inspecting methods for connection state thereof |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767748 Apparatus for detection and analysis of dna on microarrays |
| 07/27/2004 | US6767745 Dispersing microparticles uniformly comprising a nonmagnetic core with a ferromagnetic coatings, detecting the magnetic characteristics |
| 07/27/2004 | US6767733 Movement of fluids through the biosensor may be controlled to increase the sensitivity and efficiency of analyte detection |
| 07/27/2004 | US6767732 Method and apparatus for the detection of volatile products in a sample |
| 07/27/2004 | US6767715 Nitroso compounds and their use as spin traps |
| 07/27/2004 | US6767714 Diagnostic detection device and method |
| 07/27/2004 | US6767712 Models of prion disease |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767710 Prewetting stop flow test strip |
| 07/27/2004 | US6767709 Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same |
| 07/27/2004 | US6767708 Stabilized aqueous steroid immunoassay standards |
| 07/27/2004 | US6767706 Integrated active flux microfluidic devices and methods |
| 07/27/2004 | US6767705 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767702 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 07/27/2004 | US6767635 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 07/27/2004 | US6767511 Automatic analysis apparatus used for timing blood coagulation |
| 07/27/2004 | US6767510 Having nonabsorbent capillary channel composed of grooves perpendicular to fluid flow with multiple discrete capture zones; rapid multicomponent analysis |
| 07/27/2004 | US6767130 Sampling device for thermal analysis |
| 07/27/2004 | US6766865 Rotary soil probe |
| 07/27/2004 | US6766762 Indicator device for soil |
| 07/27/2004 | CA2381506C Difference detection methods using matched multiple dyes |
| 07/27/2004 | CA2316213C Cell potential measuring electrode and measuring apparatus using the same |
| 07/27/2004 | CA2206437C Method of determining remaining life of a power transmission belt |
| 07/27/2004 | CA2128600C Method and apparatus for determination of refiner mechanical pulp properties |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/24/2004 | CA2455701A1 The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/22/2004 | WO2004061458A2 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 07/22/2004 | WO2004061456A2 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | WO2004061455A1 Self-calibrated flow-through assay devices |
| 07/22/2004 | WO2004061454A1 Reduction of the hook effect in membrane-based assay devices |
| 07/22/2004 | WO2004061453A1 A protein chip for analyzing interaction between protein and substrate peptide thereof |
| 07/22/2004 | WO2004061452A1 Method of assaying antibody |
| 07/22/2004 | WO2004061451A1 Reactive chip and method for detecting bond of target substance using that chip |
| 07/22/2004 | WO2004061450A1 Predictive crude oil compatibility model |
| 07/22/2004 | WO2004061449A1 Analyzing system for the detection of reducing and oxidizing gases in a carrier gas with a metal-oxide-semiconductor sensor arrangement |
| 07/22/2004 | WO2004061448A1 Apparatus for the detection of radon gas concentration variation in the environment, method for such detection and their use in forecasting of seismic events. |
| 07/22/2004 | WO2004061446A1 Single cell analysis of membrane molecules |
| 07/22/2004 | WO2004061444A1 Thin analyzing device |
| 07/22/2004 | WO2004061436A1 Device and method for determining the physical condition of an animal |
| 07/22/2004 | WO2004061433A1 Pharmaceutical compositions with improved dissolution |
| 07/22/2004 | WO2004061423A2 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | WO2004061422A2 Bindingzyme arrays and high-throughput proteomic methods |
| 07/22/2004 | WO2004061418A2 Assay cartridges and methods of using the same |
| 07/22/2004 | WO2004061417A2 Device structure for closely spaced electrodes |
| 07/22/2004 | WO2004061416A2 Methods for attaching molecules |
| 07/22/2004 | WO2004061413A2 Method and apparatus for separation of particles in a microfluidic device |
| 07/22/2004 | WO2004061410A2 Serum biomarkers in lung cancer |
| 07/22/2004 | WO2004061408A2 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 07/22/2004 | WO2004061407A2 Glycopeptide identification and analysis |
| 07/22/2004 | WO2004061404A1 Leak detector and leak detection using helium or hydrogen as tracer gas |
| 07/22/2004 | WO2004061133A1 Association of molecules with electrodes of an array of electrodes |
| 07/22/2004 | WO2004061131A1 Multiplexed immunohistochemical assays using molecular tags |
| 07/22/2004 | WO2004061126A2 Nucleic acid hybridization assay using bridging sequence |
| 07/22/2004 | WO2004061123A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 07/22/2004 | WO2004061121A2 Method and apparatus for following cells |
| 07/22/2004 | WO2004061106A1 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same |
| 07/22/2004 | WO2004061103A1 Novel protein and its gene |
| 07/22/2004 | WO2004061102A1 Cell cycle-controlling protein and utilization thereof |
| 07/22/2004 | WO2004061101A1 Method of selecting novel immunosuppressant |
| 07/22/2004 | WO2004061088A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/22/2004 | WO2004061087A2 Methods and compositions of ecdysozoan molt inhibition |
| 07/22/2004 | WO2004061086A2 Flj10607 as modifier of the axin pathway and methods of use |
| 07/22/2004 | WO2004061084A2 Modulation of protein functionalities |
| 07/22/2004 | WO2004061077A2 Increasing gamete production with a gene switch |
| 07/22/2004 | WO2004060925A2 Multiplex polymer ligation |
| 07/22/2004 | WO2004060918A1 Detecting lipocalin |
| 07/22/2004 | WO2004060917A2 Fluorescence based t-type channel assay |
| 07/22/2004 | WO2004060860A2 Method for inhibiting the replication of herpes viruses |
| 07/22/2004 | WO2004060832A2 Fluorescent creatinine assay |
| 07/22/2004 | WO2004060390A2 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 07/22/2004 | WO2004060360A1 Use of active ingredients for the prophylaxis and/or therapy of viral diseases |